M. El Raziky

发表

Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients

I. Waked, M. Said, W. Elakel, 2017, Liver international : official journal of the International Association for the Study of the Liver.

Sofosbuvir‐based treatment regimens: real life results of 14 409 chronic HCV genotype 4 patients in Egypt

G. Shiha, I. Waked, M. Said, 2017, Alimentary pharmacology & therapeutics.

Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.

G. Esmat, W. Doss, M. Hassany, 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Optimizing treatment for HCV genotype 4: PEG‐IFN alfa 2a vs. PEG‐IFN alfa 2b; the debate continues

M. Hassany, M. Gamil, M. El kassas, 2014, Liver international : official journal of the International Association for the Study of the Liver.

Effectiveness of ravidasvir plus sofosbuvir in interferon-naïve and treated patients with chronic hepatitis C genotype-4.

M. Abdel-hamid, A. Gomaa, I. Waked, 2017, Journal of hepatology.

Human Leukocyte Antigen Class II Alleles (DQB1 and DRB1) as Predictors for Response to Interferon Therapy in HCV Genotype 4

S. El-Kamary, G. Esmat, O. Shaker, 2013, Mediators of inflammation.

ITPA gene polymorphism (94C>A) effects on ribavirin‐induced anemia during therapy in Egyptian patients with chronic hepatitis C

Amin Abdel Baki, M. El Raziky, N. Zayed, 2017, Journal of medical virology.

Impact of old Schistosomiasis infection on the use of transient elastography (Fibroscan) for staging of fibrosis in chronic HCV patients.

G. Esmat, A. Elsharkawy, A. Radwan, 2017, Acta tropica.

The Effect of Peginterferon Alpha-2a vs. Peginterferon Alpha-2b in Treatment of Naive Chronic HCV Genotype-4 Patients: A Single Centre Egyptian Study

G. Esmat, A. Salama, M. El Raziky, 2013, Hepatitis monthly.

Single nucleotide polymorphism at exon 7 splice acceptor site of OAS1 gene determines response of hepatitis C virus patients to interferon therapy

H. Sharada, M. S. Abdalla, A. Helmy, 2011, Journal of gastroenterology and hepatology.

Association Analysis of Genetic Variants of Sodium Taurocholate Co-Transporting Polypeptide NTCP Gene (SLC10A1) and HBV Infection Status in a Cohort of Egyptian Patients

V. Uversky, W. Doss, M. Hassany, 2021, Gastroenterology Insights.

Serum level of cytokeratin 19 as a diagnostic and prognostic marker in patients with HCV-related hepatocellular carcinoma

A. Elsharkawy, M. El Raziky, S. Sharaf, 2021, Egyptian Liver Journal.

High SVR rate following retreatment of non-sustained virological responders to sofosbuvir based anti-HCV therapies regardless of RAS testing: A real-life multicenter study

I. Waked, W. Elakel, G. Esmat, 2019, Expert review of gastroenterology & hepatology.

High Dose of Silymarin in Patients with Decompensated Liver Disease: A Randomized Controlled Trial.

M. El Raziky, W. Fathalah, M. A. Abdel Aziz, 2017, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.

G. Esmat, A. Elsharkawy, H. Khattab, 2013, World journal of gastroenterology.

Hepatic fibrosis and serum alpha-fetoprotein (AFP) as predictors of response to HCV treatment and factors associated with serum AFP normalisation after treatment.

G. Esmat, O. Shaker, A. Elsharkawy, 2013, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

The future for the treatment of genotype 4 chronic hepatitis C

M. Hassany, M. Gamil, M. El kassas, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Regulatory and activated effector T cells in chronic hepatitis C virus: Relation to autoimmunity

M. El Raziky, Samar Kamal Darweesh, Hanan H Fouad, 2016, World journal of hepatology.

Osteopontin gene polymorphisms as predictors for the efficacy of interferon therapy in chronic hepatitis C Egyptian patients with genotype 4

O. Shaker, Salwa Fayez, M. El Raziky, 2013, Cell biochemistry and function.

Association of vitamin D binding protein polymorphisms with response to therapy in Egyptian chronic hepatitis C patients.

A. S. Attia, Ahmed S. Attia, Ahmed M. Kamel, 2017, Journal of infection in developing countries.

Changes in liver stiffness measurements and fibrosis scores following sofosbuvir based treatment regimens without interferon

G. Esmat, M. Bourlière, A. Elsharkawy, 2017, Journal of gastroenterology and hepatology.

The adverse effects of interferon‐free regimens in 149 816 chronic hepatitis C treated Egyptian patients

H. Wedemeyer, M. Said, W. Elakel, 2018, Alimentary pharmacology & therapeutics.

Retreatment of chronic hepatitis C virus genotype-4 patients after non-structural protein 5A inhibitors' failure: efficacy and safety of different regimens

G. Esmat, W. Doss, Hend A. Mahmoud, 2020, European journal of gastroenterology & hepatology.

Efficacy and safety of ombitasvir/paritaprevir/ritonavir-based therapy in HCV patients with chronic kidney disease.

W. Elakel, W. Doss, Mai Mehrez, 2023, Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology.

Predictors of Virological Response in 3,235 Chronic HCV Egyptian Patients Treated with Peginterferon Alpha-2a Compared with Peginterferon Alpha-2b Using Statistical Methods and Data Mining Techniques.

G. Esmat, A. Salama, M. El Raziky, 2016, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.

G. Esmat, A. Elsharkawy, H. Khattab, 2013, World journal of gastroenterology.

Impact of vitamin D supplementation on sustained virological response in chronic hepatitis C genotype 4 patients treated by pegylated interferon/ribavirin.

G. Esmat, W. Doss, M. Hassany, 2015, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

IP-10 Serum Level in Chronic Hepatitis C Virus Patients: Relation to Fibrosis and Response to Combined Interferon/Ribavirin Therapy.

A. Elsharkawy, M. El Raziky, H. Gamal Eldeen, 2015, Journal of Interferon and Cytokine Research.